Prevalence of vitamin D deficiency in patients with COVID-19 admitted to a tertiary hospital in Rio Grande do Sul

Maria Julia de Diniz Jacob, Juliana Cardozo Fernandes, Paloma Dias da Cruz, Carolina Garcia Soares Leães Rech
{"title":"Prevalence of vitamin D deficiency in patients with COVID-19 admitted to a tertiary hospital in Rio Grande do Sul","authors":"Maria Julia de Diniz Jacob, Juliana Cardozo Fernandes, Paloma Dias da Cruz, Carolina Garcia Soares Leães Rech","doi":"10.54448/ijn24105","DOIUrl":null,"url":null,"abstract":"Background: Increasing data suggests a connection between vitamin D (vitD) and COVID-19. VitD may impact COVID-19 by affecting innate cellular immunity and exacerbating cytokine storms linked to severe respiratory syndrome from the virus. Objective: To assess the prevalence of vitD deficiency in COVID-19 patients hospitalized at Hospital Ernesto Dornelles and examine its links to in-hospital mortality, the need for Intensive Care Unit (ICU), patient demographics, and hospital stay duration. Methods: A cross-sectional study was performed, in which 3518 hospitalized patients with a confirmed diagnosis of COVID-19 were evaluated to obtain the prevalence of vitD deficiency, from March 2020 to August 2022. Data collection was performed using electronic medical records, excluding patients without serum levels of vitD measured during hospitalization, and including those with the exam in their medical records, which were later placed for statistical analysis. Results: 486 patients had their serum level of vitD measured, with a mean age of 68.3 years, 57.2% female, and 42.8% male. The prevalence of vitD deficiency was 60.1% (292 patients). There was no difference between the groups with and without vitD deficiency when comparing age, gender, and comorbidities. The median length of hospital stay, the need for ICU admission, and the outcome of death were significantly higher in the group with vitD deficiency (p<0.001; p=0.005; p=0.03). After adjusting for confounding factors, only the risk of ICU admission remained 1.38x higher in the group with vitD deficiency than in the group without (p=0.015), as well as age and CRF were factors with a higher risk for ICU admission. Conclusions: The prevalence of vitD deficiency in patients with COVID-19 was 60%, being associated with a higher risk of ICU admission, possibly presenting or not an association with higher mortality rates and length of stay. Therefore, further studies are needed to establish a cause-and-effect association.","PeriodicalId":137919,"journal":{"name":"International Journal of Nutrology","volume":" 47","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nutrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54448/ijn24105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Increasing data suggests a connection between vitamin D (vitD) and COVID-19. VitD may impact COVID-19 by affecting innate cellular immunity and exacerbating cytokine storms linked to severe respiratory syndrome from the virus. Objective: To assess the prevalence of vitD deficiency in COVID-19 patients hospitalized at Hospital Ernesto Dornelles and examine its links to in-hospital mortality, the need for Intensive Care Unit (ICU), patient demographics, and hospital stay duration. Methods: A cross-sectional study was performed, in which 3518 hospitalized patients with a confirmed diagnosis of COVID-19 were evaluated to obtain the prevalence of vitD deficiency, from March 2020 to August 2022. Data collection was performed using electronic medical records, excluding patients without serum levels of vitD measured during hospitalization, and including those with the exam in their medical records, which were later placed for statistical analysis. Results: 486 patients had their serum level of vitD measured, with a mean age of 68.3 years, 57.2% female, and 42.8% male. The prevalence of vitD deficiency was 60.1% (292 patients). There was no difference between the groups with and without vitD deficiency when comparing age, gender, and comorbidities. The median length of hospital stay, the need for ICU admission, and the outcome of death were significantly higher in the group with vitD deficiency (p<0.001; p=0.005; p=0.03). After adjusting for confounding factors, only the risk of ICU admission remained 1.38x higher in the group with vitD deficiency than in the group without (p=0.015), as well as age and CRF were factors with a higher risk for ICU admission. Conclusions: The prevalence of vitD deficiency in patients with COVID-19 was 60%, being associated with a higher risk of ICU admission, possibly presenting or not an association with higher mortality rates and length of stay. Therefore, further studies are needed to establish a cause-and-effect association.
南里奥格兰德州一家三级医院收治的 COVID-19 患者中维生素 D 缺乏症的患病率
背景:越来越多的数据表明,维生素 D(vitD)与 COVID-19 之间存在联系。维生素 D 可能会影响先天性细胞免疫,加剧与该病毒引起的严重呼吸综合征有关的细胞因子风暴,从而对 COVID-19 产生影响。目的评估在埃内斯托-多内尔斯医院住院的 COVID-19 患者中维生素 D 缺乏症的患病率,并研究其与院内死亡率、重症监护室(ICU)需求、患者人口统计学和住院时间的关系。研究方法2020年3月至2022年8月期间,对3518名确诊为COVID-19的住院患者进行了横断面研究,以了解维生素D缺乏症的患病率。数据收集通过电子病历进行,排除了住院期间未测量血清维生素D水平的患者,并将病历中包含检查结果的患者纳入其中,随后进行统计分析。结果486名患者测量了血清中的维生素D水平,平均年龄为68.3岁,女性占57.2%,男性占42.8%。维生素 D 缺乏症的发病率为 60.1%(292 名患者)。在比较年龄、性别和合并症时,缺乏维生素D组和缺乏维生素D组之间没有差异。维生素D缺乏症组的中位住院时间、入住重症监护室的需求和死亡结果均显著高于维生素D缺乏症组(P<0.001;P=0.005;P=0.03)。在对混杂因素进行调整后,只有维生素D缺乏症组患者入住ICU的风险仍比无维生素D缺乏症组高1.38倍(p=0.015),年龄和CRF也是入住ICU风险较高的因素。结论COVID-19患者中维生素D缺乏症的发病率为60%,与更高的入住ICU风险相关,可能与更高的死亡率和住院时间有关。因此,需要进一步研究以确定因果关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信